697P Impact of β-blockers (BB) on outcomes of metastatic renal cell carcinoma (mRCC) patients treated with nivolumab (N)

Authors :: Stéphane Oudard
Frederic Rolland
Marine Gross-Goupil
Bernard Escudier
C. Alves Costa Silva
Lionnel Geoffrois
Gwenaelle Gravis
Lisa Derosa
Sylvie Negrier
B. Laguerre
C. Dalban
Delphine Borchiellini
Christine Chevreau
Sylvain Ladoire
Florence Joly
Laurence Albiges
Emeline Colomba
Antoine Thiery-Vuillemin
Florence Tantot
Philippe Barthélémy
Source :: Annals of Oncology. 32:S710
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Renal cell carcinoma
business.industry
Internal medicine
medicine
Hematology
Nivolumab
medicine.disease
business

Tools